Bill Title: Prohibits certain insurance policies from requiring prior authorization for buprenorphine products, methadone and long acting injectable naltrexone for detoxification or maintenance treatment of substance use disorders.

Spectrum: Moderate Partisan Bill (Democrat 4-1)

Status: (Passed) 2019-12-31 - signed chap.748 [A02904 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2019-01-28	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York A02904

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York A02904 currently on file.

Social Comments on NY A02904